some news next week following these would be nice to see...it's hard to watch right now.

American Society of Nephrology – Kidney Week 2021 (November 2-7)

Research Scientist Dean Gilham, PhD will present a poster entitled: “Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells: Mechanism for Reduced Cardiac Events in CKD Patients.”

Clinical Trials on Alzheimer's Disease (CTAD) – 14th Annual Conference(November 9-12)

Research Scientist Sylwia Wasiak, PhD will present an oral presentation entitled: “The epigenetic modulator apabetalone decreases neuroinflammation in blood brain barrier cell models and LPS-treated mice.”

American Heart Association – Scientific Sessions 2021 (November 13-15)

Research Scientist Sylwia Wasiak, PhD will present a poster entitled: “Epigenetic BET Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Aortic Gene Expression in a Diet Induced Obesity Mouse Model.”

The posters may be found HERE, when available